Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39356

DNAL1 Knockout HT29 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

The DNAL1 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HT29 human colorectal adenocarcinoma line. This model disrupts the DNAL1 gene, encoding a light chain of the axonemal dynein motor complex critical for ciliary motility. DNAL1 functions downstream of the transcription factors FOXJ1 and RFX3 and interacts with dynein components DNAH5 and DNAI1. Its loss impairs mucociliary clearance and Hedgehog signaling, making the cells suitable for cilia biology, primary ciliary dyskinesia modeling, and drug toxicity studies.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HT29

    Gene Name

    DNAL1

    Gene Identifier

    NCBI Gene ID 83544

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAL1 Knockout HT29 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the DNAL1 gene has been disrupted via CRISPR/Cas9-mediated gene editing. This polyclonal population, derived from the HT29 human colorectal adenocarcinoma cell line, serves as a genetically defined loss-of-function model for investigating the roles of dynein axonemal light chain 1 in epithelial cell biology.

The HT29 cell line, originally isolated from a primary colorectal adenocarcinoma in a 44-year-old female, is a well-established model of human intestinal epithelium. HT29 cells are capable of undergoing differentiation into enterocyte-like phenotypes, exhibiting polarized monolayers, mucus production, and tight junction formation. These features render HT29 cells particularly valuable for studying epithelial barrier function, mucin secretion, and colorectal cancer progression.

DNAL1 encodes a light chain component of the axonemal outer dynein arm, a molecular motor essential for ciliary and flagellar motility. DNAL1 interacts with the dynein heavy chain DNAH5, intermediate chain DNAI1, and light chain DNALI1 within the axonemal dynein complex. Its expression is controlled by the transcription factors FOXJ1 and RFX3, which are activated by upstream Notch and Wnt signaling. DNAL1 inactivation impairs dynein complex assembly, reduces ciliary beat frequency, and consequently disrupts mucociliary clearance and Hedgehog signaling.

In the HT29 intestinal epithelial model, DNAL1 knockout permits investigation of ciliary dynein function in the context of epithelial differentiation, mucus production, and cancer-relevant signaling. HT29 cells can be differentiated into polarized monolayers that mimic the intestinal barrier and are capable of producing mucus, processes potentially influenced by the Notch, Wnt, and Hedgehog pathways crosstalk. Although HT29 are not constitutively ciliated, induction of ciliogenesis under air-liquid interface or specific media conditions allows functional assessment of ciliary motility deficits resulting from DNAL1 disruption.

This polyclonal knockout cell population is applicable to cilia biology, primary ciliary dyskinesia research, motility assays, and drug toxicity screening. Investigators can employ immunofluorescence of ciliary markers, high-speed video microscopy to measure ciliary beat frequency, western blotting for axonemal proteins, and RT-qPCR for ciliogenic transcription factors. Air-liquid interface culture enables evaluation of mucociliary clearance, complementing traditional 2D monolayer studies. Together, this model provides a versatile tool for elucidating the roles of axonemal dynein in epithelial homeostasis and disease. For additional details, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)